The occurrence of relatively higher serum titers of measles antibodies in patients with multiple sclerosis (MS) as compared with matched controls was first demonstrated by Adams and Imagawa (1) . This observation was later confirmed in a number of studies, and it has further been shown that relatively increased serum titers of antibodies against other viruses may also occur (3) . The frequency of occurrence of measles virus antibodies in cerebrospinal fluid (CSF) from patients with MS also is much higher than that in control patients (6) . A similar observation has also been made for vaccinia antibodies (10) , but a separate report could neither confirm this finding nor detect any antibodies to parainfluenza virus type 1 in CSF (5) .
In further studies of the significance of increased titers of measles antibodies in MS patients and in patients with related diseases, a comparison of antibody titers in serum and CSF was made (12, 18 ; H. Link, E. Norrby, and J. E. Olsson, submitted for publication). The titers of measles antibodies were determined by use of three different serological techniques, and for comparison tests were also made for antibodies against viral antigens assumed not to be related to the disease. The latter tests were included to determine whether a relatively increased titer of CSF antibodies against a certain virus was due to a damage of the blood-brain barrier or to a local production of antibodies within the central nervous system (CNS). It was found that a local production of measles antibodies in the CNS occurred in about 60% of patients with MS or patients with optic neuritis or myelopathy and demonstrable oligoclonal immunoglobulin G (IgG) in concentrated CSF.
The present collaborative interscandinavian study was initiated to determine whether a local production of antibodies against viruses other than measles might occur in the CNS of patients with MS. As in previous studies, a comparison was made between the relative titers in serum and CSF of antibodies against a certain virus and the corresponding serum-to-CSF ratio of antibodies against an unrelated virus antigen. It was found that a local produc- Occurrence of significantly reduced serum to CSF ratios of antibodies against different viruses. Adenovirus HE and poliovirus NE antibodies were included for reference purposes in the present study. Due to the presence of either one of these antibodies or both in higher titers in serum samples, a meaningful reference serum-to-CSF ratio was obtained in paired samples from 145 of the 150 patients included in the study. If a ratio of less than 140 is taken as subnormal, only 2% of patients in the whole material showed a subnormal ratio for both reference antibodies. This is to be expected since pronounced damage of the blood-brain barrier is a rather uncommon event in MS (22) . In a few additional cases, either one of the two reference antibodies occurred in titers giving a A significantly reduced serum-to-CSF ratio of antibodies to more than one virus was found in some patients. The frequency of occurrence of this phenomenon was similar in samples from the three countries. A reduced ratio detectable in any of the tests used was found in 71% of all patients. In 48% of the whole group, this applied to a reduced ratio in only one test, but in 16% a reduced ratio was found in tests for antibodies against two different viruses. In 7% of the whole group, reduced ratios of antibodies against three or more viruses were encounted.
Clinical and laboratory findings in MS patients with and without a significantly reduced ratio of virus antibodies serum/CSF. We tried to relate the occurrence of a reduced ratio of antibodies to any of the viruses studied (except those included for reference purposes) to time of onset and duration of the disease and the disability caused by the disease. In none of the samples could any significant correlations be found.
The presence of mononuclear cells in the CSF In the samples from all three countries, a correlation was found between the occurrence of a significantly reduced ratio of serum/CSF antibodies against one or more of the viruses studied and the presence of selectively increased concentrations of IgG in CSF. In the group of 50 Swedish MS patients, the occurrence of the significantly reduced ratio to any of the viruses studied and CSF IgG expressed in percentage of total protein showed a certain significance (P < 0.05). The mean value of CSF IgG was 14.8 (SEM ± 0.900) among the 29 patients with reduced ratios, against 11.7 (SEM + 1.054) among the 21 patients with normal ratios (P < 0.05). Similarly, in the Finnish group the mean IgG concentration in CSF of patients with a reduced ratio of measles HI antibodies differed significantly from those without a reduced ratio (P < 0.001). A similar difference of somewhat lower degree of significance (P < 0.05) was found for mumps virus HI antibodies. This study has shown that a significantly reduced ratio of virus antibodies in serum/CSF may concern not only those directed against measles virus antigens but also against certain other viruses. In agreement with previous findings (18) , our study showed a local production of measles virus antibodies in the CNS in 40 to 60% of all MS patients. Measles virus antibodies were analyzed by use of three different serological techniques, whereas only single techniques were used to study antibodies against other viruses. This should be considered when frequencies of reduced ratios of antibodies to different viruses are compared. Besides antibodies to measles, antibodies to rubella virus, mumps virus, and to some extent herpes simplex virus type 1 were found to be locally produced in the CNS of a certain fraction of MS patients. The frequency of occurrence of this local production of virus antibodies varied between 19 and 1 1'% in the whole material. Only in few cases could a local production in CNS of parainfluenza 1 virus HI antibodies be detected. It should be mentioned that the parainfluenza virus type 1 strain used in our serological tests was of murine origin and therefore partly different from the strain of parainfluenza virus type 1 isolated from two patients with MS (15) .
The proposed presence of measles virus antigen in the brain of patients with MS mentioned above has been suggested to be due to an activation of latent measles virus infections in the CNS. In analogy with this, it is possible that the local production of antibodies in the CNS to other viruses also may be due to activation of latent infections. The differences as concern the frequency of occurrence of such a local production of antibodies to a certain virus in the CNS of MS patients may reflect varying tendencies for establishment of a state of latency or different conditions of latency for different viruses. It can be inferred from the present findings that An alternative explanation for the present finding might be a nonspecific activation (without the presence of any antigen) of immune competent cells conditioned to produce antibodies against different viral antigens. However, against this speaks the recent preliminary observation (B. Vandvik and E. Norrby, manuscript in preparation) that antiviral antibodies at least in some cases represent a certain fraction of the oligoclonal IgG produced within the CNS of MS patients. Oligoclonal IgG in concentrated CSF has been absorbed onto purified measles virus antigen and then eluted at a reduced pH. Similar studies could be carried out with MS patients in whom a local production of antibodies against more than one virus can be demonstrated. In such a study, purified antigens of each of the viruses concerned could be used for absorption and elution of antibodies. Possibly oligoclonal IgG of different electrophoretic mobility might be absorbed to different virus antigens. It appears likely that the development of an oligoclonal IgG response, in cases when one is not dealing with IgG-producing tumor cells of myeloma character, should be based on a selection by antigen of cells producing antibodies of high avidity.
In the Norwegian material two patients without demonstrable oligoclonal IgG in concentrated CSF displayed a local production in CNS of antibodies to herpes simplex virus type 1. This is not due to any lack of capacity of this virus to evoke a production of specific oligoclonal IgG, since this was recently identified in concentrated CSF of cases of herpes encephalitis (Vandvik and Norrby, in preparation).
An increased frequency of occurrence of HL-A3 and HL-A7 antigens in MS patients has been demonstrated (2, 8) . In a separate study (9) (16) , patients contracting paralytic polio had HL-A3 and HL-A7 antigens in a significantly higher frequency than individuals who did not display signs of CNS involvement when infected by the virus. A further analysis of the possible importance of genetic factors in the MS disease preferably should include serological studies on the occurrence of antibodies against viral antigens.
